The fibroid growth study: determinants of therapeutic intervention.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2851130)

Published in J Womens Health (Larchmt) on May 01, 2009

Authors

Barbara J Davis1, Karen E Haneke, Kelly Miner, Ania Kowalik, J Carl Barrett, Shyamal Peddada, Donna Day Baird

Author Affiliations

1: National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA. Barbara.Davis@MPI.com

Articles by these authors

GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol (2003) 22.63

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell (2006) 8.48

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell (2005) 6.79

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature (2008) 6.02

Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol (2004) 4.87

HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J (2004) 4.26

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res (2008) 4.05

Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics. BMC Bioinformatics (2004) 3.65

Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med (2001) 3.22

Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A (2008) 2.73

Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res (2005) 2.72

BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation. Curr Biol (2004) 2.67

Gene expression analysis reveals chemical-specific profiles. Toxicol Sci (2002) 2.50

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res (2005) 2.48

Scientific collaboration results in higher citation rates of published articles. Pharmacotherapy (2006) 2.39

Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics (2005) 2.29

Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov (2002) 2.15

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer. Clin Cancer Res (2010) 2.13

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell (2009) 2.13

Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res (2005) 2.08

Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. Cancer Cell (2004) 2.05

Cytokine patterns differ seasonally between women with and without uterine leiomyomata. Am J Reprod Immunol (2013) 1.99

Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis (2004) 1.91

The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum Mol Genet (2005) 1.88

Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res (2006) 1.87

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res (2005) 1.86

Prediction of compound signature using high density gene expression profiling. Toxicol Sci (2002) 1.82

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis (2003) 1.82

The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect (2003) 1.80

Best practices for use of historical control data of proliferative rodent lesions. Toxicol Pathol (2009) 1.79

The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies. Environ Health Perspect (2003) 1.78

Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem (2004) 1.76

Has human fertility declined over time?: why we may never know. Epidemiology (2005) 1.75

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res (2005) 1.74

Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res (2004) 1.74

Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol (2003) 1.68

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene (2004) 1.63

Research misconduct policies of social science journals and impact factor. Account Res (2010) 1.61

New directions in the epidemiology of uterine fibroids. Semin Reprod Med (2010) 1.58

Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion. PLoS Biol (2004) 1.54

Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res (2003) 1.54

Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology (2002) 1.54

Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann N Y Acad Sci (2003) 1.50

Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer (2008) 1.49

Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology (2006) 1.44

Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer (2004) 1.43

Reduced fertility among overweight and obese men. Epidemiology (2006) 1.43

Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function. Mol Cancer Ther (2006) 1.43

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development. Clin Cancer Res (2004) 1.40

Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res (2009) 1.40

Research misconduct policies of scientific journals. Account Res (2009) 1.39

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res (2004) 1.36

Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell (2002) 1.36

Clusters of mutations from transient hypermutability. Proc Natl Acad Sci U S A (2005) 1.35

Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood (2004) 1.32

Closing the gaps on human chromosome 19 revealed genes with a high density of repetitive tandemly arrayed elements. Genome Res (2004) 1.30

Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog (2003) 1.30

Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Mol Biol Cell (2004) 1.27

Rapid generation of long synthetic tandem repeats and its application for analysis in human artificial chromosome formation. Nucleic Acids Res (2005) 1.26

Energy balance and carcinogenesis: underlying pathways and targets for intervention. Curr Cancer Drug Targets (2007) 1.26

Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res (2006) 1.26

Associations of abdominal fat with perceived racism and passive emotional responses to racism in African American women. Am J Public Health (2007) 1.24

PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature (2003) 1.24

Development of gut microbiota in infants not exposed to medical interventions. APMIS (2010) 1.23

Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest (2002) 1.22

The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene (2002) 1.22

Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res (2007) 1.22

Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element. Proc Natl Acad Sci U S A (2005) 1.21

Human artificial chromosome (HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells. Proc Natl Acad Sci U S A (2011) 1.21

Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch (2002) 1.20

Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci U S A (2005) 1.19

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res (2005) 1.18

On the frequency of intercourse around ovulation: evidence for biological influences. Hum Reprod (2004) 1.18

Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. Hum Mol Genet (2004) 1.17

Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab (2002) 1.16

Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring) (2007) 1.16

G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunol Immunother (2005) 1.14

Order restricted inference for multivariate binary data with application to toxicology. J Am Stat Assoc (2012) 1.14

CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med (2005) 1.11

Upregulation of the KIAA1199 gene is associated with cellular mortality. Cancer Lett (2005) 1.10

Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. Clin Cancer Res (2007) 1.10

A comparison of recalled date of last menstrual period with prospectively recorded dates. J Womens Health (Larchmt) (2005) 1.10

Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol (2004) 1.10

The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids. Proc Natl Acad Sci U S A (2004) 1.09

Oncology consent forms: failure to disclose off-site treatment availability. IRB (2009) 1.07

Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol (2002) 1.06

Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res (2006) 1.06

Segments missing from the draft human genome sequence can be isolated by transformation-associated recombination cloning in yeast. EMBO Rep (2003) 1.06

Epigenetic mechanisms in human disease. Cancer Res (2002) 1.05

Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. J Nutr (2004) 1.05

Evaluating the quality of information about alternatives to research participation in oncology consent forms. Contemp Clin Trials (2009) 1.04

Adaptive choice of the number of bootstrap samples in large scale multiple testing. Stat Appl Genet Mol Biol (2008) 1.04

Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res (2005) 1.04

Perceptions of ethical problems with scientific journal peer review: an exploratory study. Sci Eng Ethics (2008) 1.03

Proteomic profiling of S-acylated macrophage proteins identifies a role for palmitoylation in mitochondrial targeting of phospholipid scramblase 3. Mol Cell Proteomics (2011) 1.02

Self-report versus ultrasound measurement of uterine fibroid status. J Womens Health (Larchmt) (2011) 1.02

Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res (2008) 1.01